| Titre : | Two year continuation rates of contraceptive methods in France : a cohort study from the French national health insurance database (2018) |
| Auteurs : | A. AGOSTINI, Auteur ; C. GODARD, Auteur ; C. LAURENDEAU, Auteur |
| Type de document : | Article : Article de périodique |
| Dans : | EUROPEAN JOURNAL OF CONTRACEPTION & REPRODUCTIVE HEALTH CARE (THE) (Vol. 23 - N° 6, December 2018) |
| Article en page(s) : | pp.421-426 |
| Langues: | Anglais |
| Index. décimale : | 23 (Contraception) |
| Catégories : | |
| Résumé : |
A population of 42,365 women representative of the 4,109,405 French women initiating any reimbursed method between 2009 and 2012 was identified in the EGB (Echantillon Généraliste des Bénéficiaires) : 74.5% of women used oral contraceptives, 12.8% the levonorgestrel-releasing intrauterine system (LNG-IUS), 9.2% the copper intrauterine device (Cu-IUD) and 3.5% the subdermal etonogestrel (ENG) implant. The 2 year continuation rates varied from 9.1% for progestin-only oral contraceptives, 27.6% for first to second generation combined oral contraceptives (COCs) and 33.4% for third generation COCs, to 83.6% for the ENG implant, 88.1% for the Cu-IUD and 91.1% for the LNG-IUS.
Increasing the use of LARC methods, particularly among nulliparous and young women, appears to be a public health priority. This study conducted in real-world conditions showed that long-acting reversible contraceptive (LARC) methods remain rarely used in France despite high continuation rates over 2 years. |
Exemplaires (1)
| Code-barres | Cote | Support | Localisation | Section | Disponibilité | Caution pour l'emprunt |
|---|---|---|---|---|---|---|
| cedif°p°000504 | EUR | Périodiques | CEDIF Bruxelles | Périodiques | Consultation en salle de lecture Exclu du prêt |
